Hepcidin as a key iron regulator mediates glucotoxicity-induced pancreatic β-cell dysfunction. Issue 3 (March 2019)

• Record Type: Journal Article
• Authors: Shu, Tingting; Lv, Zhigang; Xie, Yuchun; Tang, Junming; Mao, Xuhua
• Is Part Of: Endocrine connections. Volume 8:Issue 3(2019)
• Page Start: 150
• Page End: 161
• Publication Date: 2019-03
• Subjects: T2DM -- hepcidin -- iron overload -- pancreatic dysfunction; Endocrinology -- Periodicals; 616.4005
• DOI: 10.1530/EC-18-0516
• Languages: English
• ISSNs: 2049-3614

Abstract

Abstract : It has been well established that glucotoxicity induces pancreatic β-cells dysfunction; however, the precise mechanism remains unclear. Our previous studies demonstrated that high glucose concentrations are associated with decreased hepcidin expression, which inhibits insulin synthesis. In this study, we focused on the role of low hepcidin level-induced increased iron deposition in β-cells and the relationship between abnormal iron metabolism and β-cell dysfunction. Decreased hepcidin expression increased iron absorption by upregulating transferrin receptor 1 (TfR1) and divalent metal transporter 1 (DMT1) expression, resulting in iron accumulation within cells. Prussia blue stain and calcein-AM assays revealed greater iron accumulation in the cytoplasm of pancreatic tissue isolated from db/db mice, cultured islets and Min6 cells in response to high glucose stimulation. Increased cytosolic iron deposition was associated with greater Fe 2+ influx into the mitochondria, which depolarized the mitochondria membrane potential, inhibited ATP synthesis, generated excessive ROS and induced oxidative stress. The toxic effect of excessive iron on mitochondrial function eventually resulted in impaired insulin secretion. The restricted iron content in db/db mice via reduced iron intake or accelerated iron clearance improved blood glucose levels with decreased fasting blood glucose (FBG), fasting blood insulin (FIns), HbA1c level, as well as improved intraperitoneal glucose tolerance test (IPGTT) results. Thus, our study may reveal the mechanism involved in the role of hepcidin in the glucotoxcity impaired pancreatic β cell function pathway.